HCPLive<sup>®</sup>: Condition Center: Exocrine Pancreatic Insufficiency Copyright (c) 2017 Intellisphere, LLC. All rights reserved. http://www.mdmag.com/conditions/exocrine-pancreatic-insufficiency/rss Exocrine Pancreatic Insufficiency en-us Sat, 30 May 2020 00:03:30 +0000 Ultrasounds Help Identify Advanced Cystic Fibrosis Liver Disease https://www.mdmag.com/medical-news/ultrasounds-cystic-fibrosis-liver-disease https://www.mdmag.com/medical-news/ultrasounds-cystic-fibrosis-liver-disease Sat, 29 Feb 2020 14:00:00 +0000 Cannabis Users With Acute Pancreatitis Less Likely to Have Necrosis, Fluid Collections https://www.mdmag.com/conference-coverage/acg-2019/cannabis-pancreatitis-necrosis-fluid https://www.mdmag.com/conference-coverage/acg-2019/cannabis-pancreatitis-necrosis-fluid Thu, 31 Oct 2019 17:00:00 +0000 Roberto Simons-Linares, MD: How a Hepatitis Viral Infection Causes Acute Pancreatitis https://www.mdmag.com/conference-coverage/acg-2019/simonslinares-hepatitis-acute-pancreatitis https://www.mdmag.com/conference-coverage/acg-2019/simonslinares-hepatitis-acute-pancreatitis Wed, 30 Oct 2019 11:00:00 +0000 Roberto Simons-Linares, MD: The Impact of Cannabis Use for Acute Necrotizing Pancreatitis https://www.mdmag.com/conference-coverage/acg-2019/simonslinares-cannabis-acute-necrotizing-pancreatitis https://www.mdmag.com/conference-coverage/acg-2019/simonslinares-cannabis-acute-necrotizing-pancreatitis Tue, 29 Oct 2019 15:00:00 +0000 FDA Approves Triple Therapy to Treat Cystic Fibrosis https://www.mdmag.com/medical-news/fda-triple-therapy-cystic-fibrosis https://www.mdmag.com/medical-news/fda-triple-therapy-cystic-fibrosis Mon, 21 Oct 2019 19:33:00 +0000 FDA Approves Symdeko Tablets for Ages 6 and Older https://www.mdmag.com/medical-news/fda-symdeko-tablets-approved-for-ages-6-and-older https://www.mdmag.com/medical-news/fda-symdeko-tablets-approved-for-ages-6-and-older Fri, 21 Jun 2019 18:10:00 +0000 Catastrophizing and Cystic Fibrosis: Fear of Breathlessness Impacts Quality of Life https://www.mdmag.com/medical-news/catastrophizing-cystic-fibrosis-fear-of-breathlessness-impacts-quality-of-life https://www.mdmag.com/medical-news/catastrophizing-cystic-fibrosis-fear-of-breathlessness-impacts-quality-of-life Mon, 15 Oct 2018 09:00:00 +0000 Antibiotics for CF Lung Infections Influenced by Oxygen, pH https://www.mdmag.com/medical-news/antibiotics-for-cf-lung-infections-influenced-by-oxygen-ph https://www.mdmag.com/medical-news/antibiotics-for-cf-lung-infections-influenced-by-oxygen-ph Mon, 01 Oct 2018 20:42:00 +0000 Telavancin: Promising Treatment Option for MRSA in Cystic Fibrosis Patients? https://www.mdmag.com/medical-news/telavancin-promising-treatment-option-mrsa-cystic-fibrosis-patients https://www.mdmag.com/medical-news/telavancin-promising-treatment-option-mrsa-cystic-fibrosis-patients Mon, 10 Sep 2018 16:00:00 +0000 Top 5 Rare Disease News of the Week—August 12, 2018 https://www.mdmag.com/medical-news/top-5-rare-disease-news-week-august-12-2018 https://www.mdmag.com/medical-news/top-5-rare-disease-news-week-august-12-2018 Sat, 18 Aug 2018 16:00:00 +0000 Stem Cell Transplant Research Leads to Cystic Fibrosis Breakthrough https://www.mdmag.com/medical-news/stem-cell-transplant-research-leads-to-cystic-fibrosis-breakthrough https://www.mdmag.com/medical-news/stem-cell-transplant-research-leads-to-cystic-fibrosis-breakthrough Fri, 17 Aug 2018 17:00:00 +0000 FDA Approves Ivacaftor as First Therapy for Underlying Cause of Cystic Fibrosis in Young Children https://www.mdmag.com/medical-news/fda-approves-ivacaftor-as-first-therapy-for-underlying-cause-of-cystic-fibrosis-in-young-children https://www.mdmag.com/medical-news/fda-approves-ivacaftor-as-first-therapy-for-underlying-cause-of-cystic-fibrosis-in-young-children Wed, 15 Aug 2018 20:40:00 +0000 FDA Approves Ivacaftor for Cystic Fibrosis in Certain Children with Mutations in <i>CFTR</i> Gene https://www.mdmag.com/medical-news/fda-approves-ivacaftor-for-cystic-fibrosis-in-certain-children-with-mutations-in-cftr-gene https://www.mdmag.com/medical-news/fda-approves-ivacaftor-for-cystic-fibrosis-in-certain-children-with-mutations-in-cftr-gene Wed, 15 Aug 2018 20:36:00 +0000 Acebilustat Reduces Frequency of Pulmonary Exacerbations in Cystic Fibrosis Patients https://www.mdmag.com/medical-news/acebilustat-reduces-frequency-of-pulmonary-exacerbations-cystic-fibrosis-patients https://www.mdmag.com/medical-news/acebilustat-reduces-frequency-of-pulmonary-exacerbations-cystic-fibrosis-patients Mon, 13 Aug 2018 20:01:00 +0000 Top 5 Rare Disease News of the Week—August 5, 2018 https://www.mdmag.com/medical-news/top-5-rare-disease-news-week-august-5-2018 https://www.mdmag.com/medical-news/top-5-rare-disease-news-week-august-5-2018 Sat, 11 Aug 2018 16:00:00 +0000 FDA Approves Lumacaftor/Ivacaftor for Younger Children with Cystic Fibrosis https://www.mdmag.com/medical-news/fda-approves-lumacaftorivacaftor-for-younger-children-with-cystic-fibrosis https://www.mdmag.com/medical-news/fda-approves-lumacaftorivacaftor-for-younger-children-with-cystic-fibrosis Tue, 07 Aug 2018 20:47:00 +0000 FDA Approves First Medicine to Treat Underlying Cause of Cystic Fibrosis in Children with Most Commo https://www.mdmag.com/medical-news/fda-approves-first-medicine-to-treat-underlying-cause-of-cystic-fibrosis-in-children-with-most-common-form-of-disease https://www.mdmag.com/medical-news/fda-approves-first-medicine-to-treat-underlying-cause-of-cystic-fibrosis-in-children-with-most-common-form-of-disease Tue, 07 Aug 2018 20:43:00 +0000 Top 5 Rare Disease News of the Week—July 1, 2018 https://www.mdmag.com/medical-news/top-5-rare-disease-news-of-the-week-july-1-2018 https://www.mdmag.com/medical-news/top-5-rare-disease-news-of-the-week-july-1-2018 Sat, 07 Jul 2018 16:00:00 +0000 Phase 3 Trials to Assess Potential Breakthrough Therapy for Patients with Cystic Fibrosis https://www.mdmag.com/medical-news/phase-3-trials-to-assess-potential-breakthrough-therapy-for-patients-with-cystic-fibrosis https://www.mdmag.com/medical-news/phase-3-trials-to-assess-potential-breakthrough-therapy-for-patients-with-cystic-fibrosis Wed, 04 Jul 2018 16:00:00 +0000 Antioxidant-Enriched Supplement Reduces Respiratory Illness in Cystic Fibrosis Patients https://www.mdmag.com/medical-news/antioxidant-enriched-supplement-reduces-respiratory-illness-in-cystic-fibrosis-patients https://www.mdmag.com/medical-news/antioxidant-enriched-supplement-reduces-respiratory-illness-in-cystic-fibrosis-patients Thu, 31 May 2018 17:29:00 +0000 Vertex Initiates Second Phase 3 of Triple Combination for Cystic Fibrosis https://www.mdmag.com/medical-news/vertex-cf-triple-combination-phase-3 https://www.mdmag.com/medical-news/vertex-cf-triple-combination-phase-3 Thu, 01 Mar 2018 15:21:00 +0000 Vertex Initiates Phase 3 of Triple Combination for Cystic Fibrosis https://www.mdmag.com/medical-news/vertex-phase-3-cystic-fibrosis https://www.mdmag.com/medical-news/vertex-phase-3-cystic-fibrosis Thu, 22 Feb 2018 19:29:00 +0000 FDA Approves Combination Therapy for Cystic Fibrosis https://www.mdmag.com/medical-news/tezacaftor-ivacaftor-combination-approved https://www.mdmag.com/medical-news/tezacaftor-ivacaftor-combination-approved Tue, 13 Feb 2018 14:03:00 +0000 Two Next Generation Correctors Advanced into Phase 3 Development for Cystic Fibrosis https://www.mdmag.com/medical-news/two-next-generation-correctors-advanced-into-phase-3-development-for-cystic-fibrosis https://www.mdmag.com/medical-news/two-next-generation-correctors-advanced-into-phase-3-development-for-cystic-fibrosis Thu, 01 Feb 2018 17:59:00 +0000 New Triple Combo Regimens Could Treat Underlying Cause of Cystic Fibrosis https://www.mdmag.com/medical-news/triple-combo-regimens-have-potential-to-treat-underlying-cause-of-cystic-fibrosis https://www.mdmag.com/medical-news/triple-combo-regimens-have-potential-to-treat-underlying-cause-of-cystic-fibrosis Wed, 19 Jul 2017 14:49:00 +0000 Incretin-Based Treatments: No Evidence of Rise in All-Cause Mortality for Patients with Type 2 Diabetes? https://www.mdmag.com/medical-news/incretinbased-treatments-no-evidence-of-rise-in-allcause-mortality-for-patients-with-type-2-diabetes https://www.mdmag.com/medical-news/incretinbased-treatments-no-evidence-of-rise-in-allcause-mortality-for-patients-with-type-2-diabetes Wed, 28 Jun 2017 20:01:56 +0000 Helping Youth with Type 1 Diabetes Improve Transition from Pediatric to Adult Care https://www.mdmag.com/medical-news/helping-youth-with-type-1-diabetes-improve-transition-from-pediatric-to-adult-care- https://www.mdmag.com/medical-news/helping-youth-with-type-1-diabetes-improve-transition-from-pediatric-to-adult-care- Tue, 20 Jun 2017 19:13:53 +0000 Individualizing Treatment in Type 2 Diabetes https://www.mdmag.com/journals/md-magazine-cardiology/2017/may-2017/individualizing-treatment-in-type-2-diabetes- https://www.mdmag.com/journals/md-magazine-cardiology/2017/may-2017/individualizing-treatment-in-type-2-diabetes- Wed, 31 May 2017 18:01:40 +0000 High Rates of Metabolic Disorder Associated with Antipsychotic Medications https://www.mdmag.com/conference-coverage/apa-2017/high-rates-of-metabolic-disorder-associated-with-antipsychotic-medications https://www.mdmag.com/conference-coverage/apa-2017/high-rates-of-metabolic-disorder-associated-with-antipsychotic-medications Sun, 21 May 2017 04:56:00 +0000 FDA Triples Uses for Cystic Fibrosis Drug https://www.mdmag.com/breaking-news/fda-triples-uses-for-cystic-fibrosis-drug https://www.mdmag.com/breaking-news/fda-triples-uses-for-cystic-fibrosis-drug Wed, 17 May 2017 09:17:00 +0000